The perfusion model used in the current study has been described by Hitzerd et al.10 Perfusion experiments were conducted in healthy, term placentas. Maternal and fetal perfusion media consisted of Krebs-Henseleit buffer at 37 °C, supplemented with heparin (final concentration; 2500 IU/L) and aerated with 95% O2 to 5% CO2. The fetal circulation (closed circuit; flow rate, 6 mL/minute) was established by cannulating the chorionic artery and corresponding vein of an intact cotyledon. Maternal circulation (closed circuit; flow rate 12 mL/minute) was created by placing 4 blunt cannulas in the intervillous space. At t=0, at a concentration of 10×Cmax, esomeprazole (50 µmol/L) or omeprazole (30 µmol/L), or no drug as a control were added to the maternal circulation. Samples of the maternal and fetal circulations were taken after 6 minutes and every 30 minutes until the end of the experiment (180 minutes) to determine the fetal-to-maternal (F/M) ratio and sFlt-1 concentration and were immediately stored at −80 °C. To establish good overlap between maternal and fetal circulations, antipyrine (100 mg/L) was added to the maternal buffer, while FITC-dextran (40 kDa, 36 mg/L) was added to the fetal circulation as a marker of integrity of the capillary bed. In order for an experiment to be successful, the F/M ratio of antipyrine had to be >0.75 and the maternal-to-fetal ratio of FITC-dextran <0.03 at t=180.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.